Results 51 to 60 of about 1,887 (161)

Modern approach to antibacterial therapy in the practice of a surgeon

Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2021
Relevance. Currently, all over the world, antibacterial therapy is widely used as a prophylaxis after surgical interventions. Currently, some data indicate the benefits of a short course, while others, in turn, indicate the benefits of a long course of ...
A. M. Morozov, A. N. Sergeev, E. M. Askerov, S. V. Zhukov, N. S. Novikova, M. A. Belyak, E. A. Sobol   +6 more
doaj   +1 more source

Effect of Telavancin (Vibativ) on Routine Coagulation Test Results

, 2011
Telavancin (Vibativ, Astellas Pharma US, Deerfield, IL) is a lipoglycopeptide antibiotic that has activity against gram-positive microorganisms, but also has the ability to bind to artificial phospholipids found in coagulation reagents.
Lisa Gandy, Robert Gosselin, William Dager, Jeffrey Gregg, Denis Dwyre, Aaron Roberts, Leslie Freeman   +6 more
core   +1 more source

β‐Lactam Adjunctive Therapy Compared to Vancomycin or Daptomycin Monotherapy in Adult Patients With Methicillin‐Resistant Staphylococcus aureus Bacteremia: An Update Systematic Review, Meta‐Analysis, and Trial Sequential Analysis

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2025, Issue 1, 2025.
Background: This study evaluated the efficacy and safety of vancomycin (VAN) or daptomycin (DAP) combined with β‐lactams (BLs) versus monotherapy (STAN) for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Methods: PubMed, Web of Science, Embase, and Cochrane Library were searched until September 30, 2024, for RCTs or cohort studies ...
Changyun Zhao, Wenchao Mao, Difan Lu, Kailun Cai, Changqin Chen, Weihang Hu, Shanmei Lv, Qi Yang, Timotius Ivan Hariyanto   +8 more
wiley   +1 more source

Telavancin in the treatment of hospital-acquired and ventilator-associated pneumonia: clinical evidence and experience

Therapeutic Advances in Respiratory Disease, 2016
Telavancin (TLV) is a lipoglycopeptide derivative of vancomycin (VAN), which has activity against Gram-positive aerobic bacteria, and is especially effective against methicillin-resistant Staphylococcus aureus (MRSA) and Gram-positive bacteria resistant ...
Adamantia Liapikou, Katerina Dimakou, Michael Toumbis   +2 more
doaj   +1 more source

Ceftaroline Exhibits Promising In Vitro Activity Against Methicillin‐Resistant Staphylococcus aureus Clinical Isolates From Alexandria, Egypt

International Journal of Microbiology, Volume 2025, Issue 1, 2025.
Introduction: Ceftaroline is a fifth‐generation cephalosporin that was recently introduced into the Egyptian market for the treatment of methicillin‐resistant Staphylococcus aureus (MRSA) infections. However, limited data are available regarding the susceptibility of MRSA isolates in Egypt to this antibacterial agent.
Hussien H. Sallam, Asmaa A. Ramadan, Nancy M. Attia, Amira ElBaradei, Sherine M. Shawky, Mohammed A. El-Kholy, Todd R. Callaway   +6 more
wiley   +1 more source

Comparative Activities of Telavancin Combined with Nafcillin, Imipenem, and Gentamicin against \u3ci\u3eStaphylococcus aureus\u3c/i\u3e

, 2013
Beta-lactams enhance the killing activity of vancomycin. Due to structural and mechanistic similarities between vancomycin and telavancin, we investigated the activity of telavancin combined with nafcillin and imipenem compared to the known synergistic ...
Gandhi, Ronak G., Patel, Meghna D., Leonard, Steven N., Supple, Megan E.   +3 more
core   +1 more source

USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016. [PDF]

PLoS ONE, 2018
Methicillin-resistant Staphylococcus aureus (MRSA) USA300 isolates have been recognized globally, not only in community but also in healthcare settings.
Josefine Enström, Inga Fröding, Christian G Giske, Karolina Ininbergs, Xiangning Bai, Gustaf Sandh, Ulla-Britt Tollström, Måns Ullberg, Hong Fang   +8 more
doaj   +1 more source

Efficacy of telavancin in comparison to linezolid in a porcine model of severe methicillin-resistant staphylococcus aureus pneumonia

, 2021
Current guidelines recommend vancomycin and linezolid as first-line agents against methicillin-resistant Staphylococcus aureus (MRSA) nosocomial pneumonia.
Antonelli M., Senussi T., Motos A., Nicolau D. P., Bobi J., Yang H., Travierso C., Pagliara F., Bringue J., Idone F., Fernandez-Barat L., Soy D., Frigola G., Pelosi P., Li Bassi G., Artigas A., Aguilera Xiol E., Meli A., Chiurazzi C., Guerrero L., Rigol M., Torres A., Yang M., Chiumello D., Ramirez J., Battaglini D.   +25 more
core   +1 more source

Dynamic distribution of systemically administered antibiotics in orthopeadically relevant target tissues and settings

APMIS, Volume 132, Issue 12, Page 992-1025, December 2024.
This review aimed to summarize the current literature on antibiotic distribution in orthopedically relevant tissues and settings where dynamic sampling methods have been used. PubMed and Embase databases were systematically searched. English‐published studies between 2004 and 2024 involving systemic antibiotic administration in orthopedically relevant ...
Maria Bech Damsgaard Nielsen, Andrea René Jørgensen, Maiken Stilling, Mads Kristian Duborg Mikkelsen, Nis Pedersen Jørgensen, Mats Bue   +5 more
wiley   +1 more source

Clinical Pharmacokinetics / Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides

, 2018
Telavancin was discovered by modifying the chemical structure of vancomycin and belongs to the group of lipoglycopeptides. It employs its antimicrobial potential through two distinct mechanisms of action: inhibition of bacterial cell wall synthesis and ...
Jalali al, Valentin, Valentin al Jalali, Zeitlinger, Markus, Markus Zeitlinger   +3 more
core   +1 more source